tiprankstipranks
Silence Therapeutics (DE:XRP2)
FRANKFURT:XRP2
Germany Market
XRP2
Silence Therapeutics
RESEARCH TOOLSreports

Silence Therapeutics (XRP2) Stock News & Sentiment

36 Followers
Silence Therapeutics: Pipeline Resilience and Upcoming Clinical Catalysts Support Buy Rating Despite AstraZeneca Exit
Premium
Ratings
Silence Therapeutics: Pipeline Resilience and Upcoming Clinical Catalysts Support Buy Rating Despite AstraZeneca Exit
1M ago
SLN
Silence Therapeutics Updates Pipeline, Reports 2025 Financial Results
Premium
Company Announcements
Silence Therapeutics Updates Pipeline, Reports 2025 Financial Results
1M ago
8K
SLN
Silence Therapeutics Appoints CFO Rhonda Hellums to Board
Premium
Company Announcements
Silence Therapeutics Appoints CFO Rhonda Hellums to Board
4M ago
8K
SLN
Silence Therapeutics Announces CEO Departure and Leadership Changes
Premium
Company Announcements
Silence Therapeutics Announces CEO Departure and Leadership Changes
4M ago
8K
SLN
Silence Therapeutics Reports Q3 2025 Financial Results
Premium
Company Announcements
Silence Therapeutics Reports Q3 2025 Financial Results
5M ago
SLN
Buy Rating Reaffirmed for Silence Therapeutics Amid Strong RNAi Pipeline and Financial Position
Premium
Ratings
Buy Rating Reaffirmed for Silence Therapeutics Amid Strong RNAi Pipeline and Financial Position
5M ago
SLN
Silence Therapeutics Completes Enrollment for Phase 2 Study
Premium
Company Announcements
Silence Therapeutics Completes Enrollment for Phase 2 Study
6M ago
8K
SLN
More DE:XRP2 News >

XRP2 News on the Web

H.C. Wainwright Reaffirms Their Buy Rating on Silence Therapeutics (SLN)
TipRanks News
Bullish
Analysts Are Bullish on Top Healthcare Stocks: Elicio Therapeutics (ELTX), Silence Therapeutics (SLN)
TipRanks News
Bullish
Chardan Capital Keeps Their Buy Rating on Silence Therapeutics (SLN)
TipRanks News
Neutral
Analysts Have Conflicting Sentiments on These Healthcare Companies: Silence Therapeutics (SLN), RxSight (RXST) and Compass Therapeutics (CMPX)
TipRanks News
Bullish
Goldman Sachs Reaffirms Their Sell Rating on Silence Therapeutics (SLN)
TipRanks News
Bearish
Silence Therapeutics: Pipeline Resilience and Upcoming Clinical Catalysts Support Buy Rating Despite AstraZeneca Exit
TipRanks News
Bullish
Wall Street Analysts See a 467.47% Upside in Silence Therapeutics (SLN): Can the Stock Really Move This High?
Zacks
Bullish
Silence Therapeutics Updates Pipeline, Reports 2025 Financial Results
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
DE:XRP2
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week100%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:XRP2’s Media Buzz Sentiment?
1 articles about DE:XRP2 were published this week. In an average week, 1 articles are published.
    What is DE:XRP2’s weekly average amount of articles?
    In an average week, 1 articles about DE:XRP2 are published.
      What is DE:XRP2’s News Sentiment?
      100% of articles about DE:XRP2 were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        NBIXNeurocrine
        STAAStaar Surgical
        SLPSimulations Plus
        OWLTOwlet
        Showing the stocks with the most bullish news sentiment over the past week